These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9692552)

  • 21. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F; Taipale M; Heiskanen A; Laiho M
    Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.
    Tomida A; Suzuki H; Kim HD; Tsuruo T
    Oncogene; 1996 Dec; 13(12):2699-705. PubMed ID: 9000144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
    Mukhopadhyay A; Banerjee S; Stafford LJ; Xia C; Liu M; Aggarwal BB
    Oncogene; 2002 Dec; 21(57):8852-61. PubMed ID: 12483537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ; White RL; Matsunami N; Neufeld KL
    Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of cell cycle arrest by methylseleninic acid.
    Zhu Z; Jiang W; Ganther HE; Thompson HJ
    Cancer Res; 2002 Jan; 62(1):156-64. PubMed ID: 11782373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.
    Park YG; Park S; Lim SO; Lee MS; Ryu CK; Kim I; Cho-Chung YS
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1213-9. PubMed ID: 11243864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.
    Moriuchi A; Hirono S; Ido A; Ochiai T; Nakama T; Uto H; Hori T; Hayashi K; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Jan; 280(1):368-73. PubMed ID: 11162525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells.
    Kim TY; Kim WI; Smith RE; Kay EP
    Mol Vis; 2001 Nov; 7():261-70. PubMed ID: 11723444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
    Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
    Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.